Literature DB >> 3518623

Aminoglycoside research 1975-1985: prospects for development of improved agents.

K E Price.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3518623      PMCID: PMC180438          DOI: 10.1128/AAC.29.4.543

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  35 in total

1.  Verdamicin, a new broad spectrum aminoglycoside antibiotic.

Authors:  M J Weinstein; G H Wagman; J A Marquez; R T Testa; J A Waitz
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

2.  A new antibiotic XK-62-2 (Sagamicin). I. Isolation, physicochemical and antibacterial properties.

Authors:  R Okachi; I Kawamoto; S Takasawa; M Yamamoto; S Sato
Journal:  J Antibiot (Tokyo)       Date:  1974-10       Impact factor: 2.649

3.  Microbiological evaluation of BB-K 8, a new semisynthetic aminoglycoside.

Authors:  K E Price; D R Chisholm; M Misiek; F Leitner; Y H Tsai
Journal:  J Antibiot (Tokyo)       Date:  1972-12       Impact factor: 2.649

4.  Letter: Syntheses of 1-n-(S)-4-amino-2-hydroxybutyryl)-kanamycin B and -3', 4'-dideoxykanamycin B active against kanamycin-resistant bacteria.

Authors:  S Kondo; K Iinuma; H Yamamoto; K Maeda; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1973-07       Impact factor: 2.649

5.  Structure of nebramycin factor 6, a new aminoglycosidic antibiotic.

Authors:  K F Koch; J A Rhoades
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

6.  The gentamicin antibiotics. 6. Gentamicin C2b, an aminoglycoside antibiotic produced by Micromonospora purpurea mutant JI-33.

Authors:  P J Daniels; C Luce; T L Nagabhushan
Journal:  J Antibiot (Tokyo)       Date:  1975-01       Impact factor: 2.649

7.  3',4'-dideoxy-kanamycin B active against kanamycin-resistant Escherichia coli and Pseudomonas aeruginosa.

Authors:  H Umezawa; S Umezawa; T Tsuchiya; Y Okazaki
Journal:  J Antibiot (Tokyo)       Date:  1971-07       Impact factor: 2.649

8.  Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibiotic.

Authors:  G H Miller; G Arcieri; M J Weinstein; J A Waitz
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

9.  Mutational biosynthesis by idiotrophs of Micromonospora purpurea. I. Conversion of aminocyclitols to new aminoglycoside antibiotics.

Authors:  D Rosi; W A Goss; S J Daum
Journal:  J Antibiot (Tokyo)       Date:  1977-01       Impact factor: 2.649

10.  Mutational biosynthesis by idiotrophs of Micromonospora purpurea. II. Conversion of non-amino containing cyclitols to aminoglycoside antibiotics.

Authors:  S J Daum; D Rosi; W A Goss
Journal:  J Antibiot (Tokyo)       Date:  1977-01       Impact factor: 2.649

View more
  11 in total

Review 1.  Aminoglycosides: activity and resistance.

Authors:  M P Mingeot-Leclercq; Y Glupczynski; P M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

2.  Once-daily aminoglycoside dosing: A new look at an old drug.

Authors:  J Conly; W Gold; S Shafran
Journal:  Can J Infect Dis       Date:  1994-09

3.  Cloning, sequencing, and use as a molecular probe of a gene encoding an aminoglycoside 6'-N-acetyltransferase of broad substrate profile.

Authors:  F J Terán; J E Suárez; M C Mendoza
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

4.  Enhanced gentamicin killing of Escherichia coli by tet gene expression.

Authors:  T L Merlin; D L Corvo; J H Gill; J K Griffith
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

Review 5.  Discovery and development of new antimicrobial agents.

Authors:  T D Gootz
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

6.  Bacterial resistance after in vitro exposure to amikacin and netilmicin.

Authors:  J A van de Klundert; J S Vliegenthart; R P Mouton
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

7.  Dactimicin, a new aminoglycoside: in vitro activity, post-antibiotic effect and interaction with other antibiotics.

Authors:  P Paglia; G Molinari; A Pesce; E A Debbia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-07       Impact factor: 3.267

Review 8.  Once-daily aminoglycoside administration: new strategies for an old drug.

Authors:  J M Kovarik; I M Hoepelman; J Verhoef
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-09       Impact factor: 3.267

9.  In vitro activity of dactimicin, a novel pseudodisaccharide aminoglycoside, compared with activities of other aminoglycosides.

Authors:  J W Gu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

Review 10.  Aminoglycosides: nephrotoxicity.

Authors:  M P Mingeot-Leclercq; P M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.